Giovanni Palladini (G Palladini)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 40

Top Venues

Università degli Studi di Pavia

Università degli Studi di Pavia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Pavia Dec 31o 2019

Italy

Full professor of Clinical Chemistry :: Molecular Medicine

Education History

Università degli Studi di Pavia

Italy

PHD

Publications

Giovanni Palladini, Paolo Milani
Diagnosis and Treatment of AL Amyloidosis. Drugs 83 (3) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Paolo Milani
Diagnosis and Treatment of AL Amyloidosis. Drugs (2023)
Eyal Lebel, Efstathios Kastritis, Giovanni Palladini, Paolo Milani, Foteini Theodorakakou, Shlomzion Aumann, Noa Lavi, Liat Shargian, Hila Magen, Yael Cohen, Moshe E Gatt, Iuliana Vaxman
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World Study. Cancers 15 (6) (2023)
Giovanni Palladini, Paolo Milani
Diagnosis and Treatment of AL Amyloidosis. Drugs 83 (3) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Eyal Lebel, Efstathios Kastritis, Giovanni Palladini, Paolo Milani, Foteini Theodorakakou, Shlomzion Aumann, Noa Lavi, Liat Shargian, Hila Magen, Yael Cohen, Moshe E Gatt, Iuliana Vaxman
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World Study. Cancers 15 (6) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Paolo Milani
Diagnosis and Treatment of AL Amyloidosis. Drugs 83 (3) (2023)
Morie A Gertz, Adam David Cohen, Raymond L Comenzo, Efstathios Kastritis, Heather J Landau, Edward N Libby, Michaela Liedtke, Vaishali Sanchorawala, Stefan Schönland, Ashutosh D Wechalekar, Jeffrey A Zonder, Giovanni Palladini, Jackie Walling, Spencer Guthrie, Christie Nie, Carol Karp, Yuying Jin, Gene G Kinney, Giampaolo Merlini
Birtamimab plus standard of care in light chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial. Blood (2023)
Alice Nevone, Francesca Lattarulo, Monica Russo, Giada Panno, Paolo Milani, Marco Basset, Maria Antonietta Avanzini, Giampaolo Merlini, Giovanni Palladini, Mario Nuvolone
A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic Datasets. Biomedicines 11 (4) (2023)
Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez-Otero, Vladimir Maisnar, Roman Hájek, Frits van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Alice Nevone, Francesca Lattarulo, Monica Russo, Giada Panno, Paolo Milani, Marco Basset, Maria Antonietta Avanzini, Giampaolo Merlini, Giovanni Palladini, Mario Nuvolone
A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic Datasets. Biomedicines 11 (4) (2023)
Alice Nevone, Maria Girelli, Silvia Mangiacavalli, Juan José Lahuerta, Paolo Milani, Pasquale Cascino, Maggie Piscitelli, Valentina Speranzini, Claudio Salvatore Cartia, Pietro Benvenuti, Ibai Goicoechea, Francesca Fazio, Marco Basset, Andrea Foli, Martina Nanci, Giulia Mazzini, Serena Caminito, Melania Antonietta Sesta, Simona Casarini, Paola Rognoni, Francesca Lavatelli, Maria Teresa Petrucci, Pier Paolo Olimpieri, Stefano Ricagno, Luca Arcaini, Giampaolo Merlini, Giovanni Palladini, Mario Nuvolone
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis. Leukemia 36 (8) (2022)
Giampaolo Merlini, Giovanni Palladini
Two-hit strategy for treating AL amyloidosis? Blood 138 (25) (2022)
Andrea Havasi, Cihan Heybeli, Nelson Leung, Avital Angel-Korman, Vaishali Sanchorawala, Oliver Cohen, Ashutosh D Wechalekar, Frank Bridoux, Insara Jaffer, Victoria Gutgarts, Hani Hassoun, Maya Levinson, Cara Rosenbaum, Paolo Milani, Giovanni Palladini, Giampaolo Merlini, Ute Hegenbart, Stefan O Schönland, Kaya Veelken, Alexander Pogrebinsky, Gheorghe Doros, Heather J Landau
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group. Blood cancer journal 12 (8) (2022)
Rosaria Russo, Margherita Romeo, Tim Schulte, Martina Maritan, Luca Oberti, Maria Monica Barzago, Alberto Barbiroli, Carlo Pappone, Luigi Anastasia, Giovanni Palladini, Luisa Diomede, Stefano Ricagno
Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains. International journal of molecular sciences 23 (2) (2022)
Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan O Schönland, Kaya Veelken, Ute Hegenbart, Susan M Geyer, Shaji K Kumar, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Michaela Liedtke, Ronald Witteles, Vaishali Sanchorawala, Raphael Szalat, Heather J Landau, Erica Petrlik, Suzanne Lentzch, Alexander Coltoff, Joan Bladé, Maria Teresa Cibeira, Oliver Cohen, Darren Foard, Ashutosh Wechalekar, Morie A Gertz
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Marco Basset, Paolo Milani, Andrea Foli, Mario Nuvolone, Pietro Benvenuti, Martina Nanci, Francesca Fabris, Claudia Bellofiore, Giampaolo Merlini, Giovanni Palladini
Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival. Blood 140 (18) (2022)
Pasquale Cascino, Alice Nevone, Maggie Piscitelli, Claudia Scopelliti, Maria Girelli, Giulia Mazzini, Serena Caminito, Giancarlo Russo, Paolo Milani, Marco Basset, Andrea Foli, Francesca Fazio, Simona Casarini, Margherita Massa, Margherita Bozzola, Jessica Ripepi, Melania Antonietta Sesta, Gloria Acquafredda, Marica De Cicco, Antonia Moretta, Paola Rognoni, Enrico Milan, Stefano Ricagno, Francesca Lavatelli, Maria Teresa Petrucci, Enkelejda Miho, Catherine Klersy, Giampaolo Merlini, Giovanni Palladini, Mario Nuvolone
Single-molecule real-time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies. American journal of hematology 97 (11) (2022)
Giovanni Palladini, Giampaolo Merlini
How I Treat AL Amyloidosis. Blood (2021)
Charlie N Saunders, Subhayan Chattopadhyay, Stefanie Huhn, Niels Weinhold, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Stefano Landi, Hartmut Goldschmidt, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Stefan O Schönland, Asta Försti, Richard Houlston, Kari Hemminki
Search for AL amyloidosis risk factors using Mendelian randomization. Blood advances 5 (13) (2021)
Giovanni Palladini, Juan José Lahuerta, Ashutosh Wechalekar, Margherita Massa, Paolo Milani, Marta Lasa, Sriram Ravichandran, Isabel Krsnik, Marco Basset, Leire Burgos, Mario Nuvolone, Ramón Lecumberri, Andrea Foli, Noemi Puig, Melania Antonietta Sesta, Margherita Bozzola, Pasquale Cascino, Alice Nevone, Jessica Ripepi, Pierpaolo Berti, Simona Casarini, Ombretta Annibali, Alberto Orfao, Jesús San F Miguel, Giampaolo Merlini
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis. Blood cancer journal 11 (2) (2021)
Giovanni Palladini, Giampaolo Merlini
When should treatment of AL amyloidosis start at relapse? Early, to prevent organ progression. Blood advances 3 (2) (2020)
Paolo Milani, Marco Basset, Mario Nuvolone, Francesca Benigna, Lara Rodigari, Francesca Lavatelli, Andrea Foli, Giampaolo Merlini, Giovanni Palladini
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy. Blood cancer journal 10 (8) (2020)
Giovanni Palladini, Giampaolo Merlini
The elusive pathogenesis of Schnitzler syndrome. Blood 131 (9) (2019)
Masayoshi Tasaki, Paolo Milani, Andrea Foli, Laura Verga, Laura Obici, Marco Basset, Margherita Bozzola, Giovanni Ferraro, Mario Nuvolone, Patrizia Morbini, Gianluca Capello, Mitsuharu Ueda, Konen Obayashi, Marco Paulli, Yukio Ando, Giampaolo Merlini, Giovanni Palladini, Francesca Lavatelli
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients. Blood 134 (3) (2019)
Subhayan Chattopadhyay, Hauke Thomsen, Niels Weinhold, Iman Meziane, Stefanie Huhn, Miguel Inacio da Silva Filho, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus M Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Stefano Landi, Roman Hajek, Göran Hallmans, Ulrika Pettersson-Kymmer, Claes Ohlsson, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Stefan O Schönland, Richard S Houlston, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance. Leukemia 34 (4) (2019)
Paolo Milani, Stefan Schönland, Giampaolo Merlini, Christoph Kimmich, Andrea Foli, Tobias Dittrich, Marco Basset, Carsten Müller-Tidow, Tilmann Bochtler, Giovanni Palladini, Ute Hegenbart
Treatment of AL amyloidosis with bendamustine: a study of 122 patients. Blood 132 (18) (2018)
Efstathios Kastritis, Ioannis Papassotiriou, Giampaolo Merlini, Paolo Milani, Evangelos Terpos, Marco Basset, Athanasios Akalestos, Francesca Russo, Erasmia Psimenou, Filia Apostolakou, Maria Roussou, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Dimitrios C Ziogas, Elektra Papadopoulou, Constantinos Pamboucas, Meletios- Athanasios Dimopoulos, Giovanni Palladini
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis. Blood 131 (14) (2018)
Paolo Milani, Marco Basset, Francesca Russo, Andrea Foli, Giampaolo Merlini, Giovanni Palladini
Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome. Blood 130 (5) (2017)
Esther Imperlini, Massimiliano Gnecchi, Paola Rognoni, Eduard Sabidò, Maria Chiara Ciuffreda, Giovanni Palladini, Guadalupe Espadas, Francesco Mattia Mancuso, Margherita Bozzola, Giuseppe Malpasso, Veronica Valentini, Giuseppina Palladini, Stefania Orrù, Giovanni Ferraro, Paolo Milani, Stefano Perlini, Francesco Salvatore, Giampaolo Merlini, Francesca Lavatelli
Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells. Scientific reports 7 (1) (2017)
Giovanni Palladini, Paolo Milani, Andrea Foli, Marco Basset, Francesca Russo, Stefano Perlini, Giampaolo Merlini
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies. Blood 131 (5) (2017)
Giovanni Palladini, Paolo Milani, Andrea Foli, Marco Basset, Francesca Russo, Stefano Perlini, Giampaolo Merlini
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis. Blood 129 (15) (2017)
Luca Oberti, Paola Rognoni, Alberto Barbiroli, Francesca Lavatelli, Rosaria Russo, Martina Maritan, Giovanni Palladini, Martino Bolognesi, Giampaolo Merlini, Stefano Ricagno
Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity. Scientific reports 7 (1) (2017)
M I da Silva Filho, A Försti, N Weinhold, I Meziane, C Campo, S Huhn, J Nickel, P Hoffmann, M M Nöthen, K-H Jöckel, S Landi, J S Mitchell, David C Johnson, G J Morgan, R Houlston, H Goldschmidt, A Jauch, P Milani, G Merlini, D Rowcieno, P Hawkins, U Hegenbart, Giovanni Palladini, A Wechalekar, S O Schönland, K Hemminki
Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma. Leukemia 31 (8) (2016)
Giovanni Palladini, Giampaolo Merlini
What is new in diagnosis and management of light chain amyloidosis? Blood 128 (2) (2016)
Giampaolo Merlini, Giovanni Palladini
Enlightening light chain deposition disease. Blood 126 (26) (2016)

Giovanni Palladini.css-eqlu8i{font-size:small;padding-left:4px;} (G Palladini)

Publication Activity (10 Years)

Top Topics

Top Venues

Giovanni Palladini (G Palladini)